GSK plc (NYSE:GSK) Receives $43.25 Consensus Target Price from Analysts
GSK plc (NYSE:GSK – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and three have issued a strong buy rating on the company. The average 1 year target […]
GSK plc (NYSE:GSK – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and three have issued a strong buy rating on the company. The average 1 year target […]
